POCI vs. LNSR, PDEX, RCEL, AVR, INFU, LAKE, PTHL, LUCD, LUNG, and OBIO
Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include LENSAR (LNSR), Pro-Dex (PDEX), Avita Medical (RCEL), Anteris Technologies Global (AVR), InfuSystem (INFU), Lakeland Industries (LAKE), Pheton (PTHL), Lucid Diagnostics (LUCD), Pulmonx (LUNG), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.
Precision Optics vs. Its Competitors
LENSAR (NASDAQ:LNSR) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.
Precision Optics has a net margin of -32.84% compared to LENSAR's net margin of -99.17%. Precision Optics' return on equity of -54.03% beat LENSAR's return on equity.
Precision Optics has lower revenue, but higher earnings than LENSAR. Precision Optics is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.
LENSAR has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500.
LENSAR presently has a consensus target price of $15.00, indicating a potential upside of 13.73%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts clearly believe LENSAR is more favorable than Precision Optics.
40.2% of LENSAR shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 38.5% of LENSAR shares are owned by company insiders. Comparatively, 13.0% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, LENSAR had 4 more articles in the media than Precision Optics. MarketBeat recorded 4 mentions for LENSAR and 0 mentions for Precision Optics. LENSAR's average media sentiment score of 0.47 beat Precision Optics' score of 0.00 indicating that LENSAR is being referred to more favorably in the media.
Summary
LENSAR beats Precision Optics on 10 of the 15 factors compared between the two stocks.
Get Precision Optics News Delivered to You Automatically
Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Precision Optics Competitors List
Related Companies and Tools
This page (NASDAQ:POCI) was last updated on 7/6/2025 by MarketBeat.com Staff
Free POCI Stock Alerts